Related Experiment Video

Updated: Dec 16, 2025

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

21.6K

Obesity is associated with severe clinical course in children with Henoch-Schonlein purpura

Hatice Adiguzel Dundar1, Mehmet Pektanc2, Meral Torun Bayram3

  • 1Faculty of Medicine, Department of Pediatric Rheumatology, Dokuz Eylul University, Izmir, Turkey. haticeadiguzel@hotmail.com.

Pediatric Nephrology (Berlin, Germany)
|July 3, 2020
PubMed

Insights

Obesity in children with Henoch-Schonlein purpura (HSP) is linked to more severe disease, including persistent rash and kidney problems. Obese children require longer treatments and more immunosuppressants.

Area of Science:

  • Pediatrics
  • Nephrology
  • Immunology

Background:

  • Henoch-Schonlein purpura (HSP) is a common vasculitis in children.
  • The impact of obesity on HSP clinical course and treatment response requires further investigation.

Purpose of the Study:

  • To evaluate the role of obesity in the clinical presentation and treatment outcomes of pediatric Henoch-Schonlein purpura.

Main Methods:

  • Retrospective review of pediatric HSP cases (2000-2018) at a tertiary hospital.
  • Comparison of demographic, clinical, and laboratory parameters between obese and non-obese HSP patients.
  • Defined persistent purpura, mild/severe nephropathy based on established criteria.

Main Results:

  • Obese HSP patients (17.6%) exhibited higher rates of persistent purpura, severe renal involvement, and hypertension.
  • Obesity correlated with more severe renal histopathology and elevated erythrocyte sedimentation rate.
  • Obese children experienced delayed symptom resolution and required longer steroid and immunosuppressive therapy.

Conclusions:

  • Obesity is associated with a more severe clinical course and poorer treatment response in pediatric HSP.
  • Findings suggest adipose tissue may influence inflammation in HSP, exacerbating disease severity and prolonging recovery.
  • Obesity necessitates tailored management strategies for children with Henoch-Schonlein purpura.
Abstract

Keywords:
Henoch-Schonlein purpuraInflammationInvolvementObesity

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.6K
Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography03:47

Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography

Published on: November 1, 2024

344

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.0K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
147
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
128
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
384
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
112
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
442